Syndax Pharmaceuticals Inc

NASDAQ:SNDX  
14.26
-0.44 (-2.99%)
Products

Syndax's Treatment For Acute Leukemias Gets FDA Fast Track Designation

Published: 06/28/2021 12:21 GMT
Syndax Pharmaceuticals Inc (SNDX) - Sndx-5613 Granted FDA Fast Track Designation for the Treatment of Relapsed/refractory Acute Leukemias.